Biogen Idec Selects Evotec OAI as a Service Provider for Process Research & Development
The companies have expanded their relationship under a master services agreement. The objective of the collaboration is to progress one of Biogen Idec's development candidates rapidly through preclinical testing into clinical trials through provision of Evotec OAI's integrated chemical and pharmaceutical development platform, EVOdevelop(TM). Evotec OAI has built a strong reputation and track record through its collaboration with Biogen Idec, which began over 5 years ago. The companies have worked together on a variety of projects including novel route selection all the way through to scale-up and cGMP manufacturing using Evotec OAI's world-class expertise in Active Pharmaceutical Ingredient development and manufacturing.
Dr Mario Polywka, President Chemical and Pharmaceutical Development Division at Evotec OAI, said: "We are extremely delighted that Biogen Idec continue to work with Evotec OAI as a partner to progress their small molecule development candidate. Our long term partnership with Biogen Idec is a strong validation of our chemical development capability and we look forward to building on our successful collaboration."
Most read news
Organizations
Other news from the department business & finance
These products might interest you
Pharmaceutical Substances by Thieme Verlag
Look up Industrial Syntheses of 2,600 APIs
Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances
AZURA Purifier + LH 2.1 by KNAUER
Preparative Liquid Chromatography - New platform for more throughput
Save time and improve reproducibility during purification
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.